PELAIA, CORRADO
PELAIA, CORRADO
Dipartimento di Scienze Mediche e Chirurgiche
An Analytical Method for Assessing Optimal Storage Conditions of Gingival Crevicular Fluid and Disclosing a Peptide Biomarker Signature of Gingivitis by MALDI-TOF MS
2018-01-01 Preiano, M; Maggisano, G; Murfuni, Ms; Villella, C; Pelaia, C; Montalcini, T; Lombardo, N; Pelaia, G; Savino, R; Terracciano, R
An integrated metabo-lipidomics profile of induced sputum for the identification of novel biomarkers in the differential diagnosis of asthma and COPD
2024-01-01 Correnti, S.; Preiano, M.; Gamboni, F.; Stephenson, D.; Pelaia, C.; Pelaia, G.; Savino, R.; D'Alessandro, A.; Terracciano, R.
Association between non-dipping blood pressure pattern and different glucometabolic profile during oral glucose tolerance test
2023-01-01 Condoleo, V; Maio, R; Cassano, V; Bonfrate, L; Pelaia, C; Armentaro, G; Miceli, S; Fiorentino, Tv; Perticone, M; Succurro, E; Andreozzi, F; Sesti, G; Sciacqua, A.
Association between right ventricular dysfunction and adverse cardiac events in mild COPD patients
2022-01-01 Armentaro, G.; Pelaia, C.; Cassano, V.; Miceli, S.; Maio, R.; Perticone, M.; Pastori, D.; Pignatelli, P.; Andreozzi, F.; Violi, F.; Sesti, G.; Sciacqua, A.
Association Between Sleep Apnea and Valvular Heart Diseases
2021-01-01 Pelaia, C.; Armentaro, G.; Miceli, S.; Perticone, M.; Toscani, A. F.; Condoleo, V.; Spinali, M.; Cassano, V.; Maio, R.; Caroleo, B.; Lombardo, N.; Arturi, F.; Perticone, F.; Sciacqua, A.
Asthma control during COVID-19 lockdown in patients with severe asthma under biological drug treatment
2021-01-01 Pelaia, C.; Casarella, A.; Marciano, G.; Muraca, L.; Rania, V.; Citraro, R.; Palleria, C.; Roberti, R.; Pelaia, G.; De Sarro, G.; Gallelli, L.
Benefits of secretion clearance with high frequency percussive ventilation in tracheostomized critically ill patients: a pilot study
2023-01-01 Garofalo, Eugenio; Rovida, Serena; Cammarota, Gianmaria; Biamonte, Eugenio; Troisi, Letizia; Cosenza, Leonardo; Pelaia, Corrado; Navalesi, Paolo; Longhini, Federico; Bruni, Andrea
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study
2021-01-01 Nolasco, S.; Crimi, C.; Pelaia, C.; Benfante, A.; Caiaffa, M. F.; Calabrese, C.; Carpagnano, G. E.; Ciotta, D.; D'Amato, M.; Macchia, L.; Pelaia, G.; Pellegrino, S.; Scichilone, N.; Scioscia, G.; Spadaro, G.; Campisi, R.; Valenti, G.; Vatrella, A.; Crimi, N.
Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study
2023-01-01 Campisi, R.; Nolasco, S.; Pelaia, C.; Impellizzeri, P.; D'Amato, M.; Portacci, A.; Ricciardi, L.; Scioscia, G.; Crimi, N.; Scichilone, N.; Foschino Barbaro, M. P.; Pelaia, G.; Carpagnano, G. E.; Vatrella, A.; Crimi, C.
Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience
2023-01-01 Scioscia, G.; Tondo, P.; Nolasco, S.; Pelaia, C.; Carpagnano, G. E.; Caiaffa, M. F.; Valenti, G.; Maglio, A.; Papia, F.; Triggiani, M.; Crimi, N.; Pelaia, G.; Vatrella, A.; Foschino Barbaro, M. P.; Crimi, C.
Benralizumab: From the basic mechanism of action to the potential use in the biological therapy of severe eosinophilic asthma
2018-01-01 Pelaia, C.; Calabrese, C.; Vatrella, A.; Busceti, M. T.; Garofalo, E.; Lombardo, N.; Terracciano, R.; Pelaia, G.
Benralizumab: From the basic mechanism of action to the potential use in the biological therapy of severe eosinophilic asthma
2018-01-01 Pelaia, C.; Calabrese, C.; Vatrella, A.; Busceti, M. T.; Garofalo, E.; Lombardo, N.; Terracciano, R.; Pelaia, G.
Biological mechanisms underlying the clinical effects of allergen-specific immunotherapy in asthmatic children
2018-01-01 Pelaia, C; Vatrella, A; Lombardo, N; Terracciano, R; Navalesi, P; Savino, R; Pelaia, G
Biological Therapy of Severe Asthma with Dupilumab, a Dual Receptor Antagonist of Interleukins 4 and 13
2022-01-01 Pelaia, Corrado; Pelaia, Giulia; Crimi, Claudia; Maglio, Angelantonio; Armentaro, Giuseppe; Calabrese, Cecilia; Sciacqua, Angela; Gallelli, Luca; Vatrella, Alessandro
Biologicals decrease psychological distress, anxiety and depression in severe asthma, despite Covid-19 pandemic
2022-01-01 Patella, Vincenzo; Pelaia, Corrado; Zunno, Roberta; Pelaia, Girolamo
Biologics in severe asthma
2022-01-01 Pelaia, Corrado; Pelaia, Giulia; Crimi, Claudia; Longhini, Federico; Lombardo, Nicola; Savino, Rocco; Sciacqua, Angela; Vatrella, Alessandro
Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma
2021-01-01 Carpagnano, G. E.; Resta, E.; Povero, M.; Pelaia, C.; D'Amato, M.; Crimi, N.; Scichilone, N.; Scioscia, G.; Resta, O.; Calabrese, C.; Pelaia, G.; Barbaro, M. P. F.
Clinical and Functional Effects of Inhaled Dual Therapy Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease: A Real-Life Study
2023-01-01 Pelaia, Corrado; Ferrante Bannera, Anna; Rotundo, Fioramante Lello; Tropea, Francesco Giuseppe; Armentaro, Giuseppe; Maglio, Angelantonio; Sciacqua, Angela; Vatrella, Alessandro; Pelaia, Girolamo
Clinical relevance of understanding mitogen-activated protein kinases involved in asthma
2020-01-01 Pelaia, Corrado; Vatrella, Alessandro; Crimi, Claudia; Gallelli, Luca; Terracciano, Rosa; Pelaia, Girolamo
Comparisons of two diaphragm ultrasound-teaching programs: a multicenter randomized controlled educational study.
2019-01-01 Garofalo, E; Bruni, A; Pelaia, C; Landoni, G; Zangrillo, A; Antonelli, M; Conti, G; Biasucci, Dg; Mercurio, G; Cortegiani, A; Giarratano, A; Vetrugno, L; Bove, T; Forfori, F; Corradi, F; Vaschetto, R; Cammarota, G; Astuto, M; Murabito, P; Bellini, V; Zambon, M; Longhini, F; Navalesi, P; Bignami, E
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| An Analytical Method for Assessing Optimal Storage Conditions of Gingival Crevicular Fluid and Disclosing a Peptide Biomarker Signature of Gingivitis by MALDI-TOF MS | 1-gen-2018 | Preiano, M; Maggisano, G; Murfuni, Ms; Villella, C; Pelaia, C; Montalcini, T; Lombardo, N; Pelaia, G; Savino, R; Terracciano, R | |
| An integrated metabo-lipidomics profile of induced sputum for the identification of novel biomarkers in the differential diagnosis of asthma and COPD | 1-gen-2024 | Correnti, S.; Preiano, M.; Gamboni, F.; Stephenson, D.; Pelaia, C.; Pelaia, G.; Savino, R.; D'Alessandro, A.; Terracciano, R. | |
| Association between non-dipping blood pressure pattern and different glucometabolic profile during oral glucose tolerance test | 1-gen-2023 | Condoleo, V; Maio, R; Cassano, V; Bonfrate, L; Pelaia, C; Armentaro, G; Miceli, S; Fiorentino, Tv; Perticone, M; Succurro, E; Andreozzi, F; Sesti, G; Sciacqua, A. | |
| Association between right ventricular dysfunction and adverse cardiac events in mild COPD patients | 1-gen-2022 | Armentaro, G.; Pelaia, C.; Cassano, V.; Miceli, S.; Maio, R.; Perticone, M.; Pastori, D.; Pignatelli, P.; Andreozzi, F.; Violi, F.; Sesti, G.; Sciacqua, A. | |
| Association Between Sleep Apnea and Valvular Heart Diseases | 1-gen-2021 | Pelaia, C.; Armentaro, G.; Miceli, S.; Perticone, M.; Toscani, A. F.; Condoleo, V.; Spinali, M.; Cassano, V.; Maio, R.; Caroleo, B.; Lombardo, N.; Arturi, F.; Perticone, F.; Sciacqua, A. | |
| Asthma control during COVID-19 lockdown in patients with severe asthma under biological drug treatment | 1-gen-2021 | Pelaia, C.; Casarella, A.; Marciano, G.; Muraca, L.; Rania, V.; Citraro, R.; Palleria, C.; Roberti, R.; Pelaia, G.; De Sarro, G.; Gallelli, L. | |
| Benefits of secretion clearance with high frequency percussive ventilation in tracheostomized critically ill patients: a pilot study | 1-gen-2023 | Garofalo, Eugenio; Rovida, Serena; Cammarota, Gianmaria; Biamonte, Eugenio; Troisi, Letizia; Cosenza, Leonardo; Pelaia, Corrado; Navalesi, Paolo; Longhini, Federico; Bruni, Andrea | |
| Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study | 1-gen-2021 | Nolasco, S.; Crimi, C.; Pelaia, C.; Benfante, A.; Caiaffa, M. F.; Calabrese, C.; Carpagnano, G. E.; Ciotta, D.; D'Amato, M.; Macchia, L.; Pelaia, G.; Pellegrino, S.; Scichilone, N.; Scioscia, G.; Spadaro, G.; Campisi, R.; Valenti, G.; Vatrella, A.; Crimi, N. | |
| Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study | 1-gen-2023 | Campisi, R.; Nolasco, S.; Pelaia, C.; Impellizzeri, P.; D'Amato, M.; Portacci, A.; Ricciardi, L.; Scioscia, G.; Crimi, N.; Scichilone, N.; Foschino Barbaro, M. P.; Pelaia, G.; Carpagnano, G. E.; Vatrella, A.; Crimi, C. | |
| Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience | 1-gen-2023 | Scioscia, G.; Tondo, P.; Nolasco, S.; Pelaia, C.; Carpagnano, G. E.; Caiaffa, M. F.; Valenti, G.; Maglio, A.; Papia, F.; Triggiani, M.; Crimi, N.; Pelaia, G.; Vatrella, A.; Foschino Barbaro, M. P.; Crimi, C. | |
| Benralizumab: From the basic mechanism of action to the potential use in the biological therapy of severe eosinophilic asthma | 1-gen-2018 | Pelaia, C.; Calabrese, C.; Vatrella, A.; Busceti, M. T.; Garofalo, E.; Lombardo, N.; Terracciano, R.; Pelaia, G. | |
| Benralizumab: From the basic mechanism of action to the potential use in the biological therapy of severe eosinophilic asthma | 1-gen-2018 | Pelaia, C.; Calabrese, C.; Vatrella, A.; Busceti, M. T.; Garofalo, E.; Lombardo, N.; Terracciano, R.; Pelaia, G. | |
| Biological mechanisms underlying the clinical effects of allergen-specific immunotherapy in asthmatic children | 1-gen-2018 | Pelaia, C; Vatrella, A; Lombardo, N; Terracciano, R; Navalesi, P; Savino, R; Pelaia, G | |
| Biological Therapy of Severe Asthma with Dupilumab, a Dual Receptor Antagonist of Interleukins 4 and 13 | 1-gen-2022 | Pelaia, Corrado; Pelaia, Giulia; Crimi, Claudia; Maglio, Angelantonio; Armentaro, Giuseppe; Calabrese, Cecilia; Sciacqua, Angela; Gallelli, Luca; Vatrella, Alessandro | |
| Biologicals decrease psychological distress, anxiety and depression in severe asthma, despite Covid-19 pandemic | 1-gen-2022 | Patella, Vincenzo; Pelaia, Corrado; Zunno, Roberta; Pelaia, Girolamo | |
| Biologics in severe asthma | 1-gen-2022 | Pelaia, Corrado; Pelaia, Giulia; Crimi, Claudia; Longhini, Federico; Lombardo, Nicola; Savino, Rocco; Sciacqua, Angela; Vatrella, Alessandro | |
| Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma | 1-gen-2021 | Carpagnano, G. E.; Resta, E.; Povero, M.; Pelaia, C.; D'Amato, M.; Crimi, N.; Scichilone, N.; Scioscia, G.; Resta, O.; Calabrese, C.; Pelaia, G.; Barbaro, M. P. F. | |
| Clinical and Functional Effects of Inhaled Dual Therapy Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease: A Real-Life Study | 1-gen-2023 | Pelaia, Corrado; Ferrante Bannera, Anna; Rotundo, Fioramante Lello; Tropea, Francesco Giuseppe; Armentaro, Giuseppe; Maglio, Angelantonio; Sciacqua, Angela; Vatrella, Alessandro; Pelaia, Girolamo | |
| Clinical relevance of understanding mitogen-activated protein kinases involved in asthma | 1-gen-2020 | Pelaia, Corrado; Vatrella, Alessandro; Crimi, Claudia; Gallelli, Luca; Terracciano, Rosa; Pelaia, Girolamo | |
| Comparisons of two diaphragm ultrasound-teaching programs: a multicenter randomized controlled educational study. | 1-gen-2019 | Garofalo, E; Bruni, A; Pelaia, C; Landoni, G; Zangrillo, A; Antonelli, M; Conti, G; Biasucci, Dg; Mercurio, G; Cortegiani, A; Giarratano, A; Vetrugno, L; Bove, T; Forfori, F; Corradi, F; Vaschetto, R; Cammarota, G; Astuto, M; Murabito, P; Bellini, V; Zambon, M; Longhini, F; Navalesi, P; Bignami, E |